ホーム600812 • SHA
add
North China Pharmaceutical Co Ltd
市場ニュース
財務情報
損益計算書
収益
純利益
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
収益 | 23.29億 | -15.04% |
営業費用 | 5.39億 | -19.20% |
純利益 | 3047.92万 | 2,035.14% |
純利益率 | 1.31 | 2,520.00% |
1 株当たりの収益 | — | — |
EBITDA | 3.63億 | 6.65% |
実効税率 | 32.92% | — |
貸借対照表
総資産
負債総額
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
現金および短期投資 | 17.22億 | 15.99% |
総資産 | 217.07億 | 0.92% |
負債総額 | 151.01億 | -0.95% |
純資産 | 66.06億 | — |
発行済み株式 | 17.16億 | — |
帳簿価格 | 1.61 | — |
総資産利益率 | 2.06% | — |
資本利益率 | 2.47% | — |
キャッシュ フロー
現金の純増減額
(CNY) | 2024年9月info | 前年比変化率 |
---|---|---|
純利益 | 3047.92万 | 2,035.14% |
営業キャッシュ フロー | 1.75億 | -46.70% |
投資キャッシュ フロー | -1.53億 | 10.80% |
財務キャッシュ フロー | -7680.19万 | 67.74% |
現金の純増減額 | -5537.75万 | 30.27% |
フリー キャッシュ フロー | -6.61億 | -459.21% |
概要
North China Pharmaceutical Group Corp., is a pharmaceutical manufacturer in China. NCPC was one of the key construction projects during China's First Five-Year Plan. After five years of construction since the foundation date in June 1953, the first successful pharmaceutical production, started in June 1958. Being one of the antibiotic producers both in technology and production scale at that time, NCPC created a history of commercial production of antibiotics in China. It has 45 years of development experience. NCPC has been taking the lead in the Chinese pharmaceutical industry in key economic indexes, ranked as one of the Top500 Enterprises and the best profit-makers in China. By the end of 2002, the total assets of the company were valued at US$2 billion, with 18,500 employees. In 2002, NCPC claimed a domestic sales revenue of US$700 million and export sales of US$100 million. Wikipedia
設立
1992/12/20
従業員数
10,159